|
|
(33 intermediate revisions not shown) |
Line 26: |
Line 26: |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/C4HSL-dependent_3OC12HSL_production" style="width:400px; margin-left:-135px;">C4HSL-dependent 3OC12HSL production</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/C4HSL-dependent_3OC12HSL_production" style="width:400px; margin-left:-135px;">C4HSL-dependent 3OC12HSL production</a></li> |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/3OC12HSL-dependent_C4HSL_production" style="width:400px; margin-left:-135px;">3OC12HSL-dependent C4HSL production</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/3OC12HSL-dependent_C4HSL_production" style="width:400px; margin-left:-135px;">3OC12HSL-dependent C4HSL production</a></li> |
- | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Symbiosis_confirmation_by_co-culture" style="width:400px; margin-left:-135px;">Symbiosis confirmation by co-culture </a></li> | + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Symbiosis_confirmation_by_co-culture" style="width:400px; margin-left:-135px;">Mutualism Confirmation ~Co-culture Assay~</a></li> |
| </ul> | | </ul> |
| </li> | | </li> |
- | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling">Modeling</a></li> | + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling">Modeling</a> |
| + | <ul> |
| + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Overview" style="width:400px; margin-left:-135px;">Overview</a></li> |
| + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Growth Conditions For Company And Customer" style="width:400px; margin-left:-135px;">Growth Conditions For Company And Customer</a></li> |
| + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Analysis of C4HSL-dependent Switch" style="width:400px; margin-left:-135px;">Analysis of C4HSL-dependent Switch</a></li> |
| + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Economic Wave" style="width:400px; margin-left:-135px;">Economic Wave</a></li> |
| + | </ul> |
| + | </li> |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">Parts</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">Parts</a></li> |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Policy_and_Practices" style="height:50px; padding-top:3px;">Policy and Practices</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Policy_and_Practices" style="height:50px; padding-top:3px;">Policy and Practices</a></li> |
Line 65: |
Line 72: |
| <p align="center"><span class="title-small">Contents</span></p> | | <p align="center"><span class="title-small">Contents</span></p> |
| <p align="left" class="info-24"><a href="#Introduction">1. Introduction </a></p> | | <p align="left" class="info-24"><a href="#Introduction">1. Introduction </a></p> |
- | <p align="left" class="info-24"><a href="#Summary">2. Summary of the experiments</a></p> | + | <p align="left" class="info-24"><a href="#Summary">2. Summary of the Experiments</a></p> |
| <p align="left" class="info-18"><a href="#Summary">2-1. 3OC12HSL-dependent CmR expression</a></p> | | <p align="left" class="info-18"><a href="#Summary">2-1. 3OC12HSL-dependent CmR expression</a></p> |
| <p align="left" class="info-18"><a href="#2.2">2-2. 3OC12HSL-dependent C4HSL production</a></p> | | <p align="left" class="info-18"><a href="#2.2">2-2. 3OC12HSL-dependent C4HSL production</a></p> |
| <p align="left" class="info-24"><a href="#Results">3. Results </a></p> | | <p align="left" class="info-24"><a href="#Results">3. Results </a></p> |
- | <p align="left" class="info-18"><a href="#Results">3.1. 3OC12HSL-depemdent CmR expression</a></p> | + | <p align="left" class="info-18"><a href="#Results">3.1. 3OC12HSL-dependent CmR expression</a></p> |
| <p align="left" class="info-18"><a href="#3.2">3.2. 3OC12HSL-dependent C4HSL production</a></p> | | <p align="left" class="info-18"><a href="#3.2">3.2. 3OC12HSL-dependent C4HSL production</a></p> |
- | <p align="left" class="info-24"><a href="#Materials">4. Materials and methods</a></p> | + | <p align="left" class="info-24"><a href="#Materials">4. Materials and Methods</a></p> |
| <p align="left" class="info-18"><a href="#4.1">4.1. Construction</a></p> | | <p align="left" class="info-18"><a href="#4.1">4.1. Construction</a></p> |
| <p align="left" class="info-18"><a href="#4.2">4.2. Assay Protocol </a></p> | | <p align="left" class="info-18"><a href="#4.2">4.2. Assay Protocol </a></p> |
Line 92: |
Line 99: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="info-18">We created a symbiosis of Company and Customer for reproducing the situation in real economy. We used signaling molecules and antibiotics resistance gene, and constructed signal-dependent signal production in our system. In our bank story, we used signaling molecules 3OC12HSL as goods. For construction of the 3OC12HSL-dependent chloramphenicol resistance (CmR) and C4HSL production module, we constructed a new part Plux-CmR-RhlI (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>). Plux-CmR-RhlI cell is an engineered E. coli that contains a 3OC12HSL-dependent RhlI generator and a constitutive LuxR generator. As a constitutive LuxR generator, we used Ptet-LuxR. In our bank story, this part reproduces Customer. (Fig. 3-4-1-1.) We confirmed that 3OC12-depedndent growth by measuring optical density, and 3OC12-dependent C4HSL production by using reporter cell.</p> </td> | + | <td><p class="info-18">We designed a signal-dependent signal production in our system by using signaling molecules and antibiotics resistance gene. In our bank story, we used signaling molecule 3OC12HSL as product.</p></td> |
| + | </tr> |
| + | <tr> |
| + | <td><p class="info-18">For construction of the 3OC12HSL-dependent chloramphenicol resistance gene product(CmR) and C4HSL production module, we constructed a new part Plux-CmR-RhlI (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>). Plux-CmR-RhlI cell is an engineered <i>E. coli</i> that contains 3OC12HSL-dependent RhlI generator and a constitutive LuxR generator. As a constitutive LuxR generator, we used Ptet-LuxR. In our bank story, this part imitates the function of Customer. (Fig. 3-4-1-1) We confirmed the 3OC12HSL-dependent growth by measuring the optical density, and 3OC12HSL-dependent C4HSL production by using reporter cell.</p></td> |
| </tr> | | </tr> |
| | | |
Line 102: |
Line 112: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><strong>Fig. 3-4-1-1. </strong>Customer’s Genetic Circuit</div></td> | + | <td><div align="center"><strong>Fig. 3-4-1-1. </strong>Genetic Circuit of Customer</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
| <td> </td> | | <td> </td> |
| </tr> | | </tr> |
- | <tr>
| + | |
- | <td><p class="info-18">In the presence of 3OC12HSL, Customer express CmR and RhlI. (C4HSL) (Fig. 3-4-1-2.) (Fig. 3-4-1-3.)</p></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-1-2.png"><img src="https://static.igem.org/mediawiki/2014/1/16/Tokyo_Tech_3-4-1-2.png" width="423" height="265" /></a></div></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td><div align="center"> <strong>Fig. 3-4-1-2.</strong> 3OC12HSL-dependent CmR expression assay Flow Chart </div></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td> </td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-1-3.png"><img src="https://static.igem.org/mediawiki/2014/b/b7/Tokyo_Tech_3-4-1-3.png" width="500" height="258" /></a></div></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td><div align="center"><strong>Fig. 3-4-1-3.</strong> 3OC12HSL-dependent C4HSL production assay Flow Chart</div></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td> </td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td><p class="info-18">The supernatant of the customer cell were used as the inducer in the reporter assay.</p></td>
| + | |
- | </tr>
| + | |
| <tr> | | <tr> |
| <td> </td> | | <td> </td> |
Line 153: |
Line 140: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="info-18">We confirmed the function of 3OC12HSL-dependent CmR expression by measuring optical density of the cell cultures containing chloramphenicol. </p> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-1-2.png"><img src="https://static.igem.org/mediawiki/2014/1/16/Tokyo_Tech_3-4-1-2.png" width="500" /></a></div></td> |
- | <p class="info-18"> In this experiment we prepared two plasmids, A and B. (See Fig. 3-4-2-1.) Concurrently with 3OC12HSL induction, we added chloramphenicol into the medium containing Customer cell and measured optical density for about 8 h to estimate the concentration of the cell. </p> | + | </tr> |
- | <div>
| + | <tr> |
- | <div></div>
| + | <td><div align="center"> <strong>Fig. 3-4-2-1.</strong> 3OC12HSL-dependent CmR expression assay flow chart </div></td> |
- | </div></td>
| + | </tr><tr> |
| + | <td><p class="info-18">We confirmed the function of 3OC12HSL-dependent CmR expression by measuring the optical density of the cell cultures containing chloramphenicol.(Fig. 3-4-2-1) </p> |
| + | <p class="info-18"> In this experiment, we prepared two plasmids A and B (See Fig. 3-4-2-2).Right after the 3OC12HSL induction, we added chloramphenicol into the medium including Customer cell. We measured the optical density for about eight hours to estimate the concentration of the cell. </p> |
| + | </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 163: |
Line 153: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><strong>Fig. 3-4-2-1.</strong> Plasmids for the experiment of 3OC12HSL-dependent CmR expression | + | <td><div align="center"><strong>Fig. 3-4-2-2.</strong> Plasmids for the experiment of 3OC12HSL-dependent CmR expression</td> |
- | <div>
| + | |
- | <div> </div>
| + | |
- | </div>
| + | |
- | </div></td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"></div></td> | + | <td> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 176: |
Line 162: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><h1>2-2. 3OC12HSL-dpendent 4CHSL production</h1></td> | + | <td><h1>2-2. 3OC12HSL-dependent C4HSL production</h1></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
| + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-1-3.png"><img src="https://static.igem.org/mediawiki/2014/b/b7/Tokyo_Tech_3-4-1-3.png" width="500" /></a></div></td> |
| + | </tr> |
| + | <tr> |
| + | <td><div align="center"><strong>Fig. 3-4-2-3.</strong> 3OC12HSL-dependent C4HSL production assay flow chart</div></td> |
| + | </tr> |
| + | <tr> |
| <td> </td> | | <td> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="info-18">We performed a reporter assay by using reporter cells to characterize the function of 3OC12HSL-dependent C4HSL production. Plux-CmR-RhlI cells contain constitutive luxR generator, and produce C4HSL (RhlI) in the presence of 3OC12HSL. C4HSL is expressed to the culture, so the supernatant of the sender cell contains C4HSL. Reporter cells are incubated in the supernatant of the culture of sender cells. In the presence of C4HSL reporter cells express GFP. We checkefd the fluorescence of reporter cells to confirm of the expression of C4HSL.The expression of the reporter cells were confirmed by Flow Cytometer.</p></td> | + | <td><p class="info-18">We performed a reporter assay by using reporter cell C, D and E to characterize the function of 3OC12HSL-dependent C4HSL production. Plux-CmR-RhlI cell containing constitutive LuxR generator expresses RhlI and produces C4HSL (RhlI) in the presence of 3OC12HSL. Since C4HSL is excreted to the culture, the supernatant of the sender cell contains C4HSL when this part works as expected.</td> |
| + | </tr> |
| + | <tr> |
| + | <td><p class="info-18"> The reporter cell was incubated in the supernatant of the culture of the sender cell. When there are C4HSL in the supernatant, the reporter cell expresses GFP.(Fig. 3-4-2-3) We checked the fluorescence intensity of the reporter cell to confirm the production of C4HSL. The fluorescence intensity of the reporter cell was measured by flow cytometer.</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-2-2.png"><img src="https://static.igem.org/mediawiki/2014/8/8b/Tokyo_Tech_3-4-2-2.png" width="500" height="176" /></a></div></td> | + | <td class="info-18"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-2-2.png"><img src="https://static.igem.org/mediawiki/2014/8/8b/Tokyo_Tech_3-4-2-2.png" width="700"/></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><strong>Fig. 3-4-2-2.</strong> Plasmids for the experiment of 3OC12HSL-dependent C4HSL production</div></td> | + | <td><div align="center"><strong>Fig. 3-4-2-4.</strong> Plasmids for the experiment of 3OC12HSL-dependent C4HSL production</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 194: |
Line 189: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="info-18">We prepared four conditions as follow. (PlacIq-CmR cell were used as the negative control.)</p></td> | + | <td><p class="info-18">We prepared the following conditions for the induction of the reporter cells. (PlacIq-CmR cell was used as the negative control of RhlI. See Fig.3-4-2-4)</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 200: |
Line 195: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">A-1) Culture containing Plux-CmR-RhlI cell with 3OC12HSL induction</td> | + | <td class="info-18">(1) Culture containing sender A (Plux-CmR-RhlI) with 3OC12HSL induction</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">A-2) Culture containing Plux-CmR-RhlI cell witout induction | + | <td class="info-18">(2) Culture containing sender A (Plux-CmR-RhlI) without induction |
- | <div> | + | </td> |
- | <div> </div>
| + | |
- | </div></td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td> </td> | + | <td class="info-18">(3) Culture containing sender B (PlacIq-CmR) with 3OC12HSL induction </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">B-1) Culture containing PlacIq-CmR cell with 3OC12HSL induction</td> | + | <td class="info-18">(4) Culture containing sender B (PlacIq-CmR) without induction </td> |
| </tr> | | </tr> |
- | <tr>
| + | <tr> |
- | <td class="info-18">B-2) Culture containing PlacIq-CmR cell without induction</td> | + | <td class="info-18">(5)5 microM of synthetic C4HSL in LB medium </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td> </td> | + | <td class="info-18">(6) DMSO in LB medium </td> |
| </tr> | | </tr> |
- | <tr>
| + | <tr> |
- | <td class="head">Reporter:</td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
| <td> </td> | | <td> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">C) Culture containing constitutive RhlR generator and Prhl(RL)-GFP cell</td> | + | <td><p class="info-18">Reporter cells</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td> </td> | + | <td class="info-18"> </td> |
- | </tr> | + | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">D) Culture containing constitutive RhlR generator and PlacUV5-GFP cell…Positive control</td> | + | <td class="info-18">C. The cell containing constitutive RhlR generator and Prhl(RL)-GFP</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td> </td> | + | <td class="info-18">D. The cell containing constitutive RhlR generator and PlacUV5-GFP…Positive control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">E) Culture containing constitutive RhlR generator and Promoter-less-GFP cell…Negative control</td> | + | <td class="info-18">E. The cell containing constitutive RhlR generator and Promoter-less-GFP…Negative control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 257: |
Line 247: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><h1>3-1. 3OC12HSL-Depemdent CmR Expression Assay</h1></td> | + | <td><h1>3-1. 3OC12HSL-dependent CmR expression assay</h1></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 263: |
Line 253: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="info-18">We got results of two type of culture condition which is difference in concentration of chloramphenicol. (Without chloramphenicol and 100 microg / ml)</p> | + | <td><p class="info-18">We tested two types of culture condition which contains different concentration of chloramphenicol(Cm). (0 and 100 microg / mL)</p> |
- | <p class="info-18"><strong>Fig.3-4-3-1.</strong> shows every cell can grow in the absence of chloramphenicol. Conversely, <strong>Fig.3-4-3-2.</strong> shows some cells cannot grow in presence of chloramphenicol.</p></td> | + | <p class="info-18">Fig. 3-4-3-1 and Fig. 3-4-3-2 show the condition in the absence and the presence of chloramphenicol, respectively.</p> |
| + | <p class="info-18">Fig. 3-4-3-1 shows that every cell can grow in the absence of chloramphenicol.</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-3-1.png"><img src="https://static.igem.org/mediawiki/2014/f/f1/Tokyo_Tech_3-4-3-1.png" width="500" height="279" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-3-1.png"><img src="https://static.igem.org/mediawiki/2014/f/f1/Tokyo_Tech_3-4-3-1.png" width="700" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><strong>Fig. 3-4-3-1.</strong> 3OC12HSL-Dependent Customer growth in no Cm</div></td> | + | <td><div align="center"><strong>Fig. 3-4-3-1.</strong> 3OC12HSL-dependent customer growth in no chloramphenicol</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 276: |
Line 267: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-3-2.png"><img src="https://static.igem.org/mediawiki/2014/5/5d/Tokyo_Tech_3-4-3-2.png" width="604" height="344" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-3-2.png"><img src="https://static.igem.org/mediawiki/2014/5/5d/Tokyo_Tech_3-4-3-2.png" width="700" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><strong>Fig.3-4-3-2.</strong> 3OC12HSL-dependent Customer growth in 100 microg / mL Cm</div></td> | + | <td><div align="center"><strong>Fig. 3-4-3-2.</strong> 3OC12HSL-dependent Customer growth in 100 microg / mL chloramphenicol</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 285: |
Line 276: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="info-18">With induction of 3OC12HSL, the cell containing Plux-CmR-RhlI can grow in the presence of chloramphenicol. However, without induction of 3OC12HSL, the cell cannot express CmR and cannot grow in the presence of chloramphenicol. As a result, only with induction of 3OC12HSL, Plux-CmR-RhlI cell can express CmR and grow well.</p></td> | + | <td><p class="info-18">On the other hand, in the presence of chloramphenicol, the cell containing Plux-CmR-RhlI can grow only when it was induced by 3OC12HSL. Without the induction of 3OC12HSL, the cell cannot express CmR and cannot grow in the presence of chloramphenicol. As a result, we confirmed that Plux-CmR-RhlI expressed CmR when induced by 3OC12HSL as expected.</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 294: |
Line 285: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><h1>3-2. 3OC12HSL-Dependent C4HSL Production Assay</h1></td> | + | <td><h1>3-2. 3OC12HSL-dependent C4HSL production assay</h1></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 300: |
Line 291: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="info-18">As <strong>Fig. 3-4-3-3.</strong> shows, when the reporter cells were incubated in the supernatant of the sender A-1, the fluorescence intensity of the reporter C increased. Comparing the results of used supernatant A-1 and A-2, reporter cell in the supernatant of A-1 (the induced Customer cell’s culture) had 95-fold higher fluorescence intensity.</p> | + | <td><p class="info-18">Fig. 3-4-3-3 shows the fluorescence intensities generated by reporter cells. When the reporter cell C (Plux-CmR-RhlI) was incubated in the condition (1) (the culture of the induced Customer cell), the fluorescence intensity of the reporter cell increased. Comparing the results of condition (1) and (2), reporter cell in the supernatant of (1) had 95-fold higher fluorescence intensity.</p> |
- | <p class="info-18">This result indicates that Company cell produced C4HSL in response to 3OC12HSL induction by the function of Plux-CmR-RhlI.</p> | + | <p class="info-18">This result indicates that Customer cell produced C4HSL in response to 3OC12HSL induction by the function of Plux-CmR-RhlI.</p> |
| <p class="info-18">From this experiment, we confirmed that a new part Plux-CmR-RhlI synthesized C4HSL (RhlI) as expected.</p></td> | | <p class="info-18">From this experiment, we confirmed that a new part Plux-CmR-RhlI synthesized C4HSL (RhlI) as expected.</p></td> |
| </tr> | | </tr> |
Line 308: |
Line 299: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><strong>Fig.3-4-3-3.</strong> Customer excretes C4HSL when C12HSL exists</div></td> | + | <td><div align="center"><strong>Fig. 3-4-3-3.</strong> Customer excretes C4HSL when C12HSL exists</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 347: |
Line 338: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"><div align="left">A. Ptet-GFP-Ptet-RhlR (psB6A1), Prhl(RL)-CmR-lasI(pSB3K3)</div></td> | + | <td class="info-18"><div align="left">A.Ptet-LuxR-Plac-RFP(pSB6A1), Plux-CmR-RhlI(pSB3K3) </div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 353: |
Line 344: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-1.png"><img src="https://static.igem.org/mediawiki/2014/5/5f/Tokyo_Tech_3-4-4-1.png" width="500" height="86" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-1.png"><img src="https://static.igem.org/mediawiki/2014/5/5f/Tokyo_Tech_3-4-4-1.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"> <strong>Fig. 3-4-4-1. </strong></div></td> | + | <td><div align="center"> <strong>Fig. 3-4-4-1. </strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 362: |
Line 353: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">B. Ptet-GFP-Ptet-RhlR (psB6A1) PlacIq-CmR (pSB3K3) (Positive control)</td> | + | <td class="info-18">B. Ptet-GFP-Ptet-RhlR (pSB6A1), PlacIq-CmR (pSB3K3)...Positive control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 368: |
Line 359: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-2.png"><img src="https://static.igem.org/mediawiki/2014/7/74/Tokyo_Tech_3-4-4-2.png" width="500" height="86" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-2.png"><img src="https://static.igem.org/mediawiki/2014/7/74/Tokyo_Tech_3-4-4-2.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 389: |
Line 380: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">A. Ptet-LuxR-Plac-RFP(pSB6A1) Plux-CmR-RhlI(pSB3K3)</td> | + | <td class="info-18">A. Ptet-LuxR-Plac-RFP(pSB6A1), Plux-CmR-RhlI(pSB3K3)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 395: |
Line 386: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-3.png"><img src="https://static.igem.org/mediawiki/2014/8/88/Tokyo_Tech_3-4-4-3.png" width="500" height="86" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-3.png"><img src="https://static.igem.org/mediawiki/2014/8/88/Tokyo_Tech_3-4-4-3.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 404: |
Line 395: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">B. Ptet-LuxR-Plac-RFP(pSB6A1) Plux-CmR(pSB3K3) (Negative control)</td> | + | <td class="info-18">B. Ptet-LuxR-Plac-RFP(pSB6A1), Plux-CmR(pSB3K3)...Negative control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 410: |
Line 401: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-4.png"><img src="https://static.igem.org/mediawiki/2014/8/8b/Tokyo_Tech_3-4-4-4.png" width="500" height="86" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-4.png"><img src="https://static.igem.org/mediawiki/2014/8/8b/Tokyo_Tech_3-4-4-4.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 425: |
Line 416: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"><p align="left" class="info-18">C. Ptet-RhlR(pSB6A1) Plux-GFP(pSB3K3)</p></td> | + | <td class="info-18"><p align="left" class="info-18">C. Ptet-RhlR(pSB6A1), Plux-GFP(pSB3K3)</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 431: |
Line 422: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-5.png"><img src="https://static.igem.org/mediawiki/2014/b/b7/Tokyo_Tech_3-4-4-5.png" width="500" height="122" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-5.png"><img src="https://static.igem.org/mediawiki/2014/b/b7/Tokyo_Tech_3-4-4-5.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><strong>Fig. 3-3-4-5.</strong></div></td> | + | <td><div align="center"><strong>Fig. 3-4-4-5.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 440: |
Line 431: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">D. Ptet-RhlR(pSB6A1) PlacUV5-GFP(pSB3K3) (Positive control)</td> | + | <td class="info-18">D. Ptet-RhlR(pSB6A1), PlacUV5-GFP(pSB3K3)...Positive control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 446: |
Line 437: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-6.png"><img src="https://static.igem.org/mediawiki/2014/a/a8/Tokyo_Tech_3-4-4-6.png" width="500" height="122" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-6.png"><img src="https://static.igem.org/mediawiki/2014/a/a8/Tokyo_Tech_3-4-4-6.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 455: |
Line 446: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">E. Ptet-RhlR(pSB6A1) Promoter-less-GFP(pSB3K3) (Negative control)</td> | + | <td class="info-18">E. Ptet-RhlR(pSB6A1), Promoter-less-GFP(pSB3K3)...Negative control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 461: |
Line 452: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-7.png"><img src="https://static.igem.org/mediawiki/2014/b/b3/Tokyo_Tech_3-4-4-7.png" width="500" height="125" /></a></div></td> | + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-4-4-7.png"><img src="https://static.igem.org/mediawiki/2014/b/b3/Tokyo_Tech_3-4-4-7.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center">Fig. 3-4-4-7.</div></td> | + | <td><div align="center"><strong>Fig. 3-4-4-7.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 480: |
Line 471: |
| | | |
| <tr> | | <tr> |
- | <td class="info-18">1. Grow cell in LB containing antibiotic over night at 37°C.</td> | + | <td class="info-18">1.Prepare the overnight culture of cell A and B at 37°C.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB containing antibiotic and grow the cells at 37°C until the observed OD590 reaches 0.5 (→fresh culture)</td> | + | <td class="info-18">2.Make a 1:100 dilution in 3 mL of fresh LB containing antibiotics and grow the cell at 37°C until the observed OD590 reaches 0.5 (→fresh culture) </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 489: |
Line 480: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 1) 3 mL of LB containing Amp and Kan + 30 microL C4HSL (final concentration is 500 microM)</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">1) 3 mL of LB containing Amp and Kan + 30 microL C4HSL (final concentration is 500 microM)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 2) 3 mL of LB containing Amp and Kan + 30 microL DMSO</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">2) 3 mL of LB containing Amp and Kan + 30 microL DMSO</td> |
| </tr> | | </tr> |
| | | |
| <tr> | | <tr> |
- | <td class="info-18"> 3) 3 mL of LB containing Amp, Kan and Cm (final concentration is 50mg/mL) + 30 microL C4HSL (final concentration is 500 microM)</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">3) 3 mL of LB containing Amp, Kan and Cm (final concentration is 100microg / mL) + 30 microL C4HSL (final concentration is 500 microM)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 4) 3 mL of LB containing Amp, Kan and Cm (final concentration is 50mg/mL) + 30 microL DMSO</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">4) 3 mL of LB containing Amp, Kan and Cm (final concentration is 100microg / mL) + 30 microL DMSO</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">4. Grow the samples of sender cells at 37°C for more than 10 hours.Measure optical density every hour. (If optical density is over 1.0, dilute the cell medium.)</td> | + | <td class="info-18">4. Grow the samples of sender cells at 37°C for more than 10 hours. Measure optical density every hour. (If optical density is over 1.0, dilute the cell medium.)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 512: |
Line 503: |
| | | |
| <tr> | | <tr> |
- | <td class="info-18">1. Prepare the supernatant of the sender cell</td> | + | <td class="info-18">Prepare the supernatant of the sender cell</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">2. Grow the colony of sender cell in LB containing antibiotic O/N at 37°C.</td> | + | <td class="info-18">1. Grow the colony of sender cell in LB containing antibiotic O/N at 37°C.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">3. Make a 1:100 dilution in 3 mL of fresh LB containing antibiotic and grow the cells at 37°C until the observed OD590 reaches 0.5.</td> | + | <td class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB containing antibiotic and grow the cells at 37°C until the observed OD590 reaches 0.5.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">4. Add 30 microL of the culture containing the cells in the following medium.</td> | + | <td class="info-18">3. Add 30 microL of the culture containing the cells in the following medium.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 1) Add 30 microL of 500 microM 3OC12HSL to 3 mL LB containing Amp and Kan</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">a) Add 30 microL of 500 microM 3OC12HSL to 3 mL LB containing Amp and Kan</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 2) Add 30 microL DMSO to 3 mL LB containing Amp and Kan</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">b) Add 30 microL DMSO to 3 mL LB containing Amp and Kan</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">5 .Grow the samples of sender cell at 37°C for 8 hours.</td> | + | <td class="info-18">4 .Grow the samples of sender cell at 37°C for 8 hours.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">6. Centrifuge sample at 9000x g, 4°C for 1minute.Filter sterilize supernatant. (Pore size is 0.22 microm. ) Use this supernatant in reporter assay.</td> | + | <td class="info-18">5. Centrifuge sample at 9000x g, 4°C for 1minute. Filter sterilize supernatant. (Pore size is 0.22 microm. ) Use this supernatant in reporter assay.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 545: |
Line 536: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB+ antibiotic and grow the cells at 37°C until you reach an 0.5 in OD590 (fresh culture).</td> | + | <td class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB+ antibiotics and grow the cells at 37°C until you reach an 0.5 in OD590 (fresh culture).</td> |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td class="info-18">3. Add 30 microL of the culture containing reporter cells in the following medium.</td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td class="info-18"> 1) 2.7 mL filtrate of A① +600 microL LB</td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 2) 2.7 mL filtrate of A② +600 microL LB</td> | + | <td class="info-18">3. Add 30 microL of the culture containing reporter cell in the following medium.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 3) 2.7 mL filtrate of B① +600 microL LB</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">1) 2.7 mL filtrate of Aa +300 microL LB</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 4) 2.7 mL filtrate of B② +600 microL LB</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">2) 2.7 mL filtrate of Ab +300 microL LB</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 5) 2.7 mL filtrate of C① +600 microL LB</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">3) 2.7 mL filtrate of Ba +300 microL LB</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 6) 2.7 mL filtrate of C② +600 microL LB</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">4) 2.7 mL filtrate of Bb +300 microL LB</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 7) 3 mL LB + 500 microM C4HSL 30 microM (final concentration is 5 microM)</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">5) 3 mL LB + 500 microM C4HSL 30 microM (final concentration is 5 microM)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td class="info-18"> 8) 3 mL LB + DMSO 30 microL</td> | + | <td colspan="2" class="info-18" style="text-indent:50px;">6) 3 mL LB + DMSO 30 microL</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |